Tizona Therapeutics Funding: $70M Raised, Series D (2016)
Tizona Therapeutics is based in South San Francisco, CA. It has raised $70M in total funding. Latest round: Series D.
Tizona Therapeutics funding overview
Tizona Therapeutics is based in South San Francisco, CA. Tizona Therapeutics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in March 2016. The round record for Tizona Therapeutics runs through 2016; nothing later has been disclosed. Investors on record include Canaan Partners, Bioqube Ventures, Forbion, Omega Funds, Gilde Healthcare, Jeito Capital and 6 others. 12 distinct backers are named across the disclosed rounds.
Frequently asked about Tizona Therapeutics funding
How much has Tizona Therapeutics raised?
Tizona Therapeutics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Tizona Therapeutics?
Canaan Partners, Bioqube Ventures, Forbion, Omega Funds, Gilde Healthcare, Jeito Capital are named among the investors backing Tizona Therapeutics.
What was the latest Tizona Therapeutics funding round?
The most recent disclosed round is a Series D, announced in March 2016.
Where is Tizona Therapeutics based?
Tizona Therapeutics is based in South San Francisco, CA.
When did Tizona Therapeutics last raise?
The last disclosed Tizona Therapeutics round closed in March 2016 at Series D.
Tizona Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.
